[Hismanal--a non-sedating H1 antihistaminic].

  • 1 January 1985
    • journal article
    • clinical trial
    • p. 59-66
Abstract
The intake of antihistamines with CNS depressing side effects leads to a multiple increase of risk for accidents with lethal results in traffic. 12 special pharmacopsychological trials, e.g. at the Royal Air Force Institut, Great Britain; at the Association for Research into Accident Causes, Cologne; and the Department of Pharmacotherapy (Drugs and Driving Research Group), University of Utrecht, Netherlands, showed Hismanal to have neither sedation nor performance reducing side effects.

This publication has 0 references indexed in Scilit: